Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer [Phase 1]
A Phase 1 trial update investigates pembrolizumab in combination with aflibercept in patients with advanced cancers, including melanoma, col…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
A completed Travera Inc trial evaluating TraveraRTGx and a tumor-cell biomarker intended to guide rapid therapy decisions across multiple ca…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
A completed clinical trial update evaluating niraparib in patients with ovarian cancer in routine clinical practice.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors [Phase 2]
Jazz Pharmaceuticals is conducting a Phase 2 trial of Zanidatamab in HER2-expressing tumors across multiple cancers. The study is currently …
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Study of Intra-operative Imaging in Women With Ovarian Cancer [Phase 3]
A Phase 3 study evaluating intra-operative imaging in women with ovarian cancer is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Study of Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP Inhibitor [NA]
Apatinib plus letrozole, with or without fluzoparib, are being studied for estrogen receptor-positive, platinum-sensitive recurrent ovarian …
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
ESPERANZA is an external control arm study of trastuzumab deruxtecan (T-DXd) for patients with HER2 IHC3+ solid tumors, sponsored by AstraZe…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer [Phase 3]
A Phase 3 study evaluating romiplostim for chemotherapy-induced thrombocytopenia in adults with non-small cell lung cancer, ovarian cancer, …
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 [Phase 2]
Update on a Phase 2 study of disitamab vedotin in HER2-expressing solid tumors, currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients [Phase 3]
Phase 3 trial comparing simple follow-up to exploratory laparotomy plus HIPEC in colorectal cancer patients with limited peritoneal metastas…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating STRO-002 in Chinese adults with epithelial ovarian cancer and other advanced malignant solid tumors ha…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers [Phase 1, Phase 2]
This clinical trial update describes a CD70-targeted CAR-T cell therapy using patients' peripheral blood lymphocytes to treat CD70-expressin…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability [Phase 2]
Phase 2 trial evaluating pembrolizumab in patients with metastatic, recurrent, or locally advanced cancers associated with BRCA1/BRCA2, POLD…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 trial evaluating a carboplatin/gemcitabine hydrochloride/berzosertib combination in patients with recurrent or metastatic ovarian, f…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib [Phase 2]
A Phase II trial evaluating nivolumab, bevacizumab, and rucaparib in peritoneal cancer, ovarian cancer, and fallopian tube cancer; results h…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial evaluating oregovomab in combination with chemotherapy in the neoadjuvant setting for newly diagnosed advanced epithelial ovar…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer [Phase 1]
Phase 1 study to evaluate NMS-03305293 in adults with relapsed ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery [NA]
Completed a clinical trial evaluating high-purity Type-I collagen for peritoneal reconstruction after cytoreductive surgery. The trial targe…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial results evaluating metformin in combination with chemotherapy for patients with stage III–IV ovarian, fallopian tube,…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Estrogen, Diet, Genetics and Endometrial Cancer
Memorial Sloan Kettering Cancer Center is conducting a trial examining how estrogen, diet, and genetics relate to endometrial cancer; the st…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: GYNecologic Cancer-Related COGnitive Impairment [NA]
This clinical trial update indicates completion of a study on gynecologic cancer-related cognitive impairment. The study enrolled patients w…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients [Phase 1]
Phase 1 clinical trial evaluating fecal microbiota transplantation for immune-checkpoint inhibitor–induced diarrhea or colitis in patients w…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy [Phase 2]
Phase 2 trial completed to assess feasibility and quality of life of a second-look laparoscopy with hyperthermic intraperitoneal chemotherap…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating the combination of Azenosertib (ZN-c3) and Niraparib in pl…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer [NA]
The trial investigating phenotypic characterization of tumor-infiltrating lymphocytes in ovarian cancer and fallopian tube cancer at diagnos…